MicroVention Announces First Patient Enrolled in the STRAIT Study with the New BOBBY™ Balloon Guide Catheter

Aliso Viejo, CA – April 20, 2022 – MicroVention, Inc., a wholly owned subsidiary of Terumo Corporation, announced the successful completion of its first enrollment in a multi-center, prospective EU observational study called STRAIT, to evaluate the Safety and Performance of the BOBBY Balloon Guide Catheter for Endovascular Treatment of Acute Ischemic Stroke. The BOBBY […]

Read More…


Lower-Profile Web Intrasaccular Aneurysm Treatment Device Receives FDA Approval

MicroVention, Inc., a U.S.-based subsidiary of Terumo and a global neurovascular company, announced today the FDA Approval of the PMA Supplement for the WEB 17 System, a new addition to the WEB Aneurysm Embolization System for the treatment of intracranial wide neck bifurcation aneurysms. The WEB 17 System, designed with the latest microbraid technology, features […]

Read More…


MIVI Neuroscience Receives IDE to Study Q Aspiration Catheter

MIVI Neuroscience announced that the FDA has approved an investigational device exemption to initiate a human clinical study of the MIVI Q aspiration catheter in the United States.  EVaQ is a prospective, multicenter, single-arm study of the Q revascularization system for neurointervention in acute ischemic stroke.  According to the company, the study will assess the […]

Read More…



Balt USA, LLC Announces CE Mark Obtained for Titan™ Aspiration Catheter

The Titan catheter line consists of a highly navigable, large bore aspiration catheter and a smaller bore catheter for navigation and support. Balt USA, LLC announced today it has obtained CE mark for the Titan aspiration catheter.  The Titan catheter line consists of a highly navigable, large bore (.070″) aspiration catheter and a smaller bore […]

Read More…